These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17267290)

  • 81. Use and safety of antiepileptic drugs in psychiatric inpatients-data from the AMSP study.
    Druschky K; Bleich S; Grohmann R; Engel RR; Kleimann A; Stübner S; Greil W; Toto S
    Eur Arch Psychiatry Clin Neurosci; 2018 Mar; 268(2):191-208. PubMed ID: 28766129
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Levetiracetam in patients with epilepsy and chronic liver disease: observations in a case series.
    Bilo L; Meo R; de Leva MF; De Simone R; Di Nocera P; Pisani F; Striano S
    Clin Neuropharmacol; 2008; 31(4):221-5. PubMed ID: 18670245
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy.
    Luciano AL; Shorvon SD
    Ann Neurol; 2007 Oct; 62(4):375-81. PubMed ID: 17253624
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Once-daily extended-release levetiracetam as adjunctive treatment of partial-onset seizures in patients with epilepsy: a double-blind, randomized, placebo-controlled trial.
    Peltola J; Coetzee C; Jiménez F; Litovchenko T; Ramaratnam S; Zaslavaskiy L; Lu ZS; Sykes DM;
    Epilepsia; 2009 Mar; 50(3):406-14. PubMed ID: 19317886
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Antiepileptic drugs and visual function.
    Verrotti A; Manco R; Matricardi S; Franzoni E; Chiarelli F
    Pediatr Neurol; 2007 Jun; 36(6):353-60. PubMed ID: 17560495
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature.
    Brandt C; Fueratsch N; Boehme V; Kramme C; Pieridou M; Villagran A; Woermann F; Pohlmann-Eden B
    Epilepsy Behav; 2007 Aug; 11(1):133-9. PubMed ID: 17485241
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Impact of the current antiepileptic drugs on quality of life of epileptic patients].
    Rudakova IG; Morozova OS; Kotov AS
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; Suppl 3():36-40. PubMed ID: 19618712
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cognitive, affective, and behavioral side events in adults secondary to antiepileptic drug use.
    Mattson RH
    Rev Neurol Dis; 2004; 1 Suppl 1():S10-7. PubMed ID: 16400290
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Rates and predictors of patient-reported cognitive side effects of antiepileptic drugs: An extended follow-up.
    Javed A; Cohen B; Detyniecki K; Hirsch LJ; Legge A; Chen B; Bazil C; Kato K; Buchsbaum R; Choi H
    Seizure; 2015 Jul; 29():34-40. PubMed ID: 26076842
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders-a pharmacoepidemiological study and clinical implications.
    Baftiu A; Johannessen Landmark C; Rusten IR; Feet SA; Johannessen SI; Larsson PG
    Eur J Clin Pharmacol; 2016 Oct; 72(10):1245-1254. PubMed ID: 27411937
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Risk factors predisposing to psychotic symptoms during levetiracetam therapy: A retrospective study.
    Pinckaers FME; Boon ME; Majoie MHJM
    Epilepsy Behav; 2019 Nov; 100(Pt A):106344. PubMed ID: 31525554
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Ketter's hypothesis of the mood effects of antiepileptic drugs coupled to the mechanism of action of topiramate and levetiracetam.
    Roberts GM; Majoie HJ; Leenen LA; Bootsma HP; Kessels AG; Aldenkamp AP; Leonard BE
    Epilepsy Behav; 2005 May; 6(3):366-72. PubMed ID: 15820345
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Practical strategies for switching to newer antiepileptic drugs.
    Kuzniecky RI; Mortati K
    Rev Neurol Dis; 2005; 2(4):186-98. PubMed ID: 16622396
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Analysis of antiseizure drug-related adverse reactions from the electronic health record using the common data model.
    Choi SA; Kim H; Kim S; Yoo S; Yi S; Jeon Y; Hwang H; Kim KJ
    Epilepsia; 2020 Apr; 61(4):610-616. PubMed ID: 32162687
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Educating lay carers of people with learning disability in epilepsy awareness and in the use of rectal diazepam: a suggested teaching protocol for use by healthcare personnel.
    Sterrick M; Foley J
    Health Bull (Edinb); 1999 May; 57(3):198-204. PubMed ID: 12811896
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Review of treatment options for refractory epilepsy: new medications and vagal nerve stimulation.
    Cramer JA; Ben Menachem E; French J
    Epilepsy Res; 2001 Nov; 47(1-2):17-25. PubMed ID: 11673017
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Comparative effectiveness of eight antiepileptic drugs in adults with focal refractory epilepsy: the influence of age, gender, and the sequence in which drugs were introduced onto the market.
    Mäkinen J; Peltola J; Raitanen J; Alapirtti T; Rainesalo S
    J Neurol; 2017 Jul; 264(7):1345-1353. PubMed ID: 28567538
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Epilepsy, learning disability and anti-convulsant drug status.
    Coughlan BJ
    Ment Health Care; 1997 Sep; 1(1):25-8. PubMed ID: 9400201
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Antiepileptic drug-induced skin reactions: a retrospective study and analysis in 3793 Chinese patients with epilepsy.
    Wang XQ; Lang SY; Shi XB; Tian HJ; Wang RF; Yang F
    Clin Neurol Neurosurg; 2012 Sep; 114(7):862-5. PubMed ID: 22321756
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Behavioral adverse effects of antiepileptic drugs in epilepsy.
    Eddy CM; Rickards HE; Cavanna AE
    J Clin Psychopharmacol; 2012 Jun; 32(3):362-75. PubMed ID: 22544012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.